Press release
Transdermal Growth Support Solutions Gain Traction as Parents Seek Height Management Before Growth Plate Closure
Child wearing Hautuki transdermal growth patch
TDDS-Based Products Appeal to Parents Through Enhanced Convenience and Compliance
As parental interest in children's height development continues to surge, transdermal patch-based growth support solutions are emerging as a compelling alternative to traditional oral supplements.
Image: https://www.abnewswire.com/upload/2025/08/6def5abec02881b17cbd81ba7c56c98b.jpg
Child wearing Hautuki [https://hautuki.sg/] growth Support Pach
Search Volume Surge Reflects Growing Demand
Recent market analysis shows the pediatric growth supplement market expanded 15.2% year-over-year in the first half of 2024. Search terms like "patch-type growth supplements" and "transdermal absorption nutrients" have experienced exponential increases, with leading products such as 'Hautuki [https://hautuki.sg/]' gaining word-of-mouth popularity among parents.
TDDS Technology Highlights Convenience Advantages
Transdermal Drug Delivery System (TDDS)-based patch products offer several distinctive advantages:
* 24-hour continuous absorption capability
* Minimized gastrointestinal side effects
* Reduced risk of missed doses
* Decreased child resistance to treatment
Industry experts note, "Products like Hautuki and other patch-based solutions are driving continuous market expansion by simultaneously securing convenience and safety."
Image: https://www.abnewswire.com/upload/2025/08/4dcb7468e3b06e7382d50ac5c7715ba6.jpg
Young child measuring height during the critical growth window before growth plate closure.
Medical Experts Emphasize Critical Growth Window
According to pediatric endocrinology experts, a child's final adult height results from genetic factors (23%) and environmental factors (77%) including nutrition, sleep, and physical activity.
A pediatric endocrinologist from Seoul National University Hospital explained, "The period before growth plate closure, particularly from late elementary through early middle school years, represents the golden window for height development."
Market Outlook
Health functional food research shows projected 12% average annual growth for the pediatric growth supplement market over the next five years. Industry experts anticipate that comprehensive care products integrating AI-based growth prediction and personalized nutrition will dominate future markets, with leading brands including Hautuki [https://hautuki.sg/] focusing development on these emerging trends.
Media Contact
Company Name: Glovertise
Contact Person: Erick
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=transdermal-growth-support-solutions-gain-traction-as-parents-seek-height-management-before-growth-plate-closure]
Phone: 01091916367
Address:38, Yeongdong-daero 112-gil #706
City: Gangnam-gu
State: Seoul
Country: Korea
Website: https://glovertise.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transdermal Growth Support Solutions Gain Traction as Parents Seek Height Management Before Growth Plate Closure here
News-ID: 4137373 • Views: …
More Releases from ABNewswire
Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, …
The Key Asthma Companies in the market include - GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharmaceuticals, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Cumberland Pharmaceuticals, Pulmatrix Inc., and others.
DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Asthma, historical and forecasted epidemiology as well as the Asthma market trends in the United States,…
Car T Cell Therapy For Multiple Myeloma Market Growth to Accelerate in Forecast …
The Key Car T Cell Therapy For Multiple Myeloma Companies in the market include- Johnson & Johnson (Janssen), Bristol-Myers Squibb, Bluebird bio, Novartis, Nanjing IASO Biotherapeutics, Gadeta, Allogene Therapeutics, Celyad Oncology, Luminary Therapeutics, Caribou Biosciences, Cellectis SA, bluebird bio, Juno Therapeutics, CRISPR Therapeutics, and others.
DelveInsight's "Car T Cell Therapy For Multiple Myeloma Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Car T Cell Therapy For…
LiftmyCV Expands Automated AI Job Search to 10 Platforms
LiftmyCV's AI job search agent now supports Greenhouse, Wellfound and Glassdoor, as the company continues scaling its automation across more than 10 leading job boards and ATS platforms.
London, UK - 7th August, 2025 - LiftmyCV, a fast-growing startup building AI tools for job seekers, has announced a major expansion of its Automated AI Job Search [https://www.liftmycv.com/automated-job-search/] system. With new integrations for Greenhouse, Glassdoor, and Wellfound, the platform now supports full…
With Dementia On The Rise Are There Steps An Aging Population Can Take To Reduce …
According to a study at NYU Langone Health [https://nyulangone.org/news/united-states-dementia-cases-estimated-double-2060], dementia cases in the U.S. could double over the next 35 years. A new study [https://www.hopkinsmedicine.org/health/wellness-and-prevention/the-hidden-risks-of-hearing-loss#:~:text=In%20a%20study%20that%20tracked,more%20likely%20to%20develop%20dementia.] led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests severe hearing loss significantly increases the likelihood of dementia, especially in those who do not use hearing enhancement devices.
The Center for Disease Control (CDC) [https://www.cdc.gov/niosh/topics/noise/reducenoiseexposure/noise.html]estimates that 22 million workers are exposed to…
More Releases for Hautuki
Hautuki Patch Demonstrates Growth Potential and Safety in Clinical Study
Hautuki Clinically Proven to Support Height Growth and Ensure Safety
Custics announced that its height-supporting nutrient patch, Hautuki, has been proven effective and safe through a clinical study conducted at Bestian Hospital over the course of approximately one year.
Image: https://www.abnewswire.com/upload/2025/05/75daaface7cea909f35fd494150fea0f.PNG
The study was conducted over 11 months, from January to November 2024, and involved 40 children between the ages of 5 and 12.
After eight weeks, the group that used the Hautuki patch…
CUSTICS SINGAPORE's Growth Nutrient Patch 'Hautuki' Completes Clinical Study
Image: https://www.abnewswire.com/upload/2025/01/d0c11fb6ef950d96ffc92b987934691b.jpg
CUSTICS SINGAPORE PTE. LTD. (hereafter referred to as "CUSTICS SINGAPORE [https://hautuki.sg/]") has successfully completed clinical study on its 'Hautuki [https://hautuki.sg/]' growth nutrient patch in collaboration with Bestian Hospital, demonstrating its effectiveness in promoting height growth and confirming its safety. The study was conducted in adherence to Good Clinical Practice (GCP) standards and the approval of the Institutional Review Board (IRB), ensuring its reliability.
From January to November 2024, the study…
Hautuki, A Globally Recognized Innovative Patch Type Nutrition Solution for Chil …
Hautuki, an innovative children's nutrition product manufactured in South Korea, is gaining global recognition. Exported to countries including the United States, Singapore, Hong Kong, Taiwan, Malaysia, Indonesia, China, and the Philippines, Hautuki has established itself as a trusted brand in international markets.
CUSTICS, the company behind Hautuki, operates legal entities in South Korea, Singapore, Taiwan, and Hong Kong, strengthening its global presence. Based on its vision to "shine and illuminate," CUSTICS…
HAUTUKI Innovates Efficient Vitamin D Delivery for Children through Transdermal …
Recent nutritional surveys conducted both domestically and internationally indicate that more than 80% of children in their growth phase suffer from vitamin D deficiency or insufficiency. Research also shows that children with stunted growth are more prone to vitamin D deficiency compared to their peers. In countries with frequent rainy or overcast days, ensuring adequate vitamin D intake is naturally more challenging.
Image: https://www.abnewswire.com/uploads/d2d7d3db97fca5f29490d3971d5e13d5.jpg
CUSTICS Inc. (CEO LEE KANG IL), in their…
Custics Singapore's HAUTUKI Secures FDA OTC Product Registration and Excels in S …
Custics Singapore announces that HAUTUKI has achieved a significant milestone by securing registration as an OTC Product with the U.S. FDA
HAUTUKI, a cutting-edge product developed through technology transferred from Seoul National University, integrates a unique blend of vitamins and nutrients designed to amplify its effectiveness. At the core of HAUTUKI's innovation is a patented peptide ligand from the Department of Biotechnology at Seoul National University. This advanced technology is engineered…
CUSTICS Launches Hautuki as an OTC Product in Singapore
CUSTICS SINGAPORE PTE. LTD. has announced that its product, Hautuki, has already completed registration with the U.S. FDA Administration OTC Product.
According to a company representative, Hautuki was developed by CUSTICS Co., Ltd. using TDDS technology previously acquired from Seoul National University. This innovative patch integrates vitamins and various nutrients and is specifically designed to support children's growth.
Image: https://www.abnewswire.com/uploads/85ea01f2e25cff2bd5d8e29463a3d6d2.png
The technology is the "Pore-Permeable Transdermal Peptide Ligand," a patented innovation from the…
